nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorcyclizine—Ifenprodil—GRIN1—bipolar disorder	0.0414	0.116	CrCbGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD5—bipolar disorder	0.0389	0.0607	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0327	0.051	CbGpPWpGaD
Chlorcyclizine—Ifenprodil—GRIN2B—bipolar disorder	0.0255	0.0711	CrCbGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—HTR1A—bipolar disorder	0.0227	0.0354	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—HTR2C—bipolar disorder	0.0219	0.0342	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD1—bipolar disorder	0.0219	0.0342	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD3—bipolar disorder	0.0212	0.0331	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD4—bipolar disorder	0.0206	0.0321	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD2—bipolar disorder	0.0192	0.0299	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0191	0.0298	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0189	0.0294	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0184	0.0287	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0184	0.0287	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0179	0.0278	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0173	0.027	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0162	0.0252	CbGpPWpGaD
Chlorcyclizine—HRH1—IL-4 Signaling Pathway—GATA3—bipolar disorder	0.0148	0.0231	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—HTR2A—bipolar disorder	0.0135	0.021	CbGpPWpGaD
Chlorcyclizine—Mazindol—SLC6A3—bipolar disorder	0.0134	0.0373	CrCbGaD
Chlorcyclizine—Diphenylpyraline—SLC6A3—bipolar disorder	0.0127	0.0355	CrCbGaD
Chlorcyclizine—Cinnarizine—CACNA1C—bipolar disorder	0.0118	0.0329	CrCbGaD
Chlorcyclizine—Loxapine—DRD5—bipolar disorder	0.0117	0.0328	CrCbGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.0113	0.0176	CbGpPWpGaD
Chlorcyclizine—HRH1—G alpha (q) signalling events—DGKH—bipolar disorder	0.0106	0.0166	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—DRD4—bipolar disorder	0.0103	0.0287	CrCbGaD
Chlorcyclizine—Mazindol—SLC6A4—bipolar disorder	0.01	0.0279	CrCbGaD
Chlorcyclizine—Benzatropine—SLC6A3—bipolar disorder	0.00975	0.0272	CrCbGaD
Chlorcyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00951	0.0148	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—DRD3—bipolar disorder	0.00888	0.0248	CrCbGaD
Chlorcyclizine—Mirtazapine—SLC6A3—bipolar disorder	0.00826	0.023	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00752	0.0117	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—HTR2C—bipolar disorder	0.00745	0.0208	CrCbGaD
Chlorcyclizine—Chlorphenamine—SLC6A3—bipolar disorder	0.00739	0.0206	CrCbGaD
Chlorcyclizine—HRH1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00737	0.0115	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—HTR1A—bipolar disorder	0.00724	0.0202	CrCbGaD
Chlorcyclizine—Cyproheptadine—HTR2C—bipolar disorder	0.00723	0.0202	CrCbGaD
Chlorcyclizine—Prochlorperazine—DRD3—bipolar disorder	0.00721	0.0201	CrCbGaD
Chlorcyclizine—Cyproheptadine—HTR1A—bipolar disorder	0.00702	0.0196	CrCbGaD
Chlorcyclizine—HRH1—G alpha (q) signalling events—TACR1—bipolar disorder	0.00685	0.0107	CbGpPWpGaD
Chlorcyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00659	0.0103	CbGpPWpGaD
Chlorcyclizine—Mianserin—DRD3—bipolar disorder	0.00652	0.0182	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00644	0.01	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—SLC6A4—bipolar disorder	0.00618	0.0172	CrCbGaD
Chlorcyclizine—Mirtazapine—DRD2—bipolar disorder	0.00614	0.0171	CrCbGaD
Chlorcyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00613	0.00955	CbGpPWpGaD
Chlorcyclizine—Mianserin—SLC6A3—bipolar disorder	0.00607	0.0169	CrCbGaD
Chlorcyclizine—Prochlorperazine—HTR2C—bipolar disorder	0.00606	0.0169	CrCbGaD
Chlorcyclizine—Loxapine—DRD4—bipolar disorder	0.00601	0.0168	CrCbGaD
Chlorcyclizine—Cyproheptadine—DRD2—bipolar disorder	0.00596	0.0166	CrCbGaD
Chlorcyclizine—HRH1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00558	0.0087	CbGpPWpGaD
Chlorcyclizine—Chlorphenamine—SLC6A4—bipolar disorder	0.00553	0.0154	CrCbGaD
Chlorcyclizine—Mianserin—HTR2C—bipolar disorder	0.00548	0.0153	CrCbGaD
Chlorcyclizine—HRH1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00548	0.00854	CbGpPWpGaD
Chlorcyclizine—Mianserin—HTR1A—bipolar disorder	0.00532	0.0148	CrCbGaD
Chlorcyclizine—Cinnarizine—DRD2—bipolar disorder	0.00519	0.0145	CrCbGaD
Chlorcyclizine—Loxapine—DRD3—bipolar disorder	0.00518	0.0145	CrCbGaD
Chlorcyclizine—Loxapine—DRD1—bipolar disorder	0.00509	0.0142	CrCbGaD
Chlorcyclizine—Clozapine—DRD4—bipolar disorder	0.00505	0.0141	CrCbGaD
Chlorcyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00499	0.00779	CbGpPWpGaD
Chlorcyclizine—Prochlorperazine—DRD2—bipolar disorder	0.00499	0.0139	CrCbGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD5—bipolar disorder	0.0049	0.00764	CbGpPWpGaD
Chlorcyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.0049	0.00763	CbGpPWpGaD
Chlorcyclizine—Loxapine—SLC6A3—bipolar disorder	0.00482	0.0135	CrCbGaD
Chlorcyclizine—Mirtazapine—HTR2A—bipolar disorder	0.00475	0.0132	CrCbGaD
Chlorcyclizine—Cyproheptadine—HTR2A—bipolar disorder	0.0046	0.0128	CrCbGaD
Chlorcyclizine—Mianserin—SLC6A4—bipolar disorder	0.00454	0.0127	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00454	0.00707	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00454	0.00707	CbGpPWpGaD
Chlorcyclizine—Mianserin—DRD2—bipolar disorder	0.00451	0.0126	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00438	0.00683	CbGpPWpGaD
Chlorcyclizine—Loxapine—HTR2C—bipolar disorder	0.00435	0.0121	CrCbGaD
Chlorcyclizine—Clozapine—DRD3—bipolar disorder	0.00435	0.0121	CrCbGaD
Chlorcyclizine—Clozapine—DRD1—bipolar disorder	0.00427	0.0119	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00423	0.0066	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00423	0.0066	CbGpPWpGaD
Chlorcyclizine—Loxapine—HTR1A—bipolar disorder	0.00422	0.0118	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.0041	0.00639	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00398	0.0062	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00376	0.00585	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00371	0.00578	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.0037	0.00576	CbGpPWpGaD
Chlorcyclizine—Clozapine—HTR2C—bipolar disorder	0.00365	0.0102	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00363	0.00565	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00363	0.00565	CbGpPWpGaD
Chlorcyclizine—Loxapine—SLC6A4—bipolar disorder	0.00361	0.0101	CrCbGaD
Chlorcyclizine—Loxapine—DRD2—bipolar disorder	0.00359	0.01	CrCbGaD
Chlorcyclizine—Clozapine—HTR1A—bipolar disorder	0.00355	0.00989	CrCbGaD
Chlorcyclizine—HRH1—GPCR ligand binding—ADM—bipolar disorder	0.00355	0.00553	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00351	0.00548	CbGpPWpGaD
Chlorcyclizine—Mianserin—HTR2A—bipolar disorder	0.00349	0.00973	CrCbGaD
Chlorcyclizine—HRH1—GPCR ligand binding—TSHB—bipolar disorder	0.00345	0.00539	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—TACR1—bipolar disorder	0.00345	0.00539	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00341	0.00532	CbGpPWpGaD
Chlorcyclizine—HRH1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00336	0.00524	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00318	0.00495	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DGKH—bipolar disorder	0.00303	0.00472	CbGpPWpGaD
Chlorcyclizine—Clozapine—DRD2—bipolar disorder	0.00301	0.0084	CrCbGaD
Chlorcyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.003	0.00468	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—HTR1A—bipolar disorder	0.00286	0.00446	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—TAC1—bipolar disorder	0.00282	0.00439	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD5—bipolar disorder	0.00277	0.00432	CbGpPWpGaD
Chlorcyclizine—Loxapine—HTR2A—bipolar disorder	0.00277	0.00773	CrCbGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD1—bipolar disorder	0.00276	0.00431	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—HTR2C—bipolar disorder	0.00276	0.00431	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DGKH—bipolar disorder	0.00275	0.00429	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—RGS4—bipolar disorder	0.00272	0.00424	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD3—bipolar disorder	0.00267	0.00417	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.0026	0.00405	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD4—bipolar disorder	0.0026	0.00405	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD5—bipolar disorder	0.00252	0.00392	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—RGS4—bipolar disorder	0.00247	0.00385	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD2—bipolar disorder	0.00242	0.00377	CbGpPWpGaD
Chlorcyclizine—Clozapine—HTR2A—bipolar disorder	0.00233	0.00649	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00222	0.00347	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—TRPC3—bipolar disorder	0.0021	0.00327	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—ADM—bipolar disorder	0.002	0.00312	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00195	0.00304	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—TSHB—bipolar disorder	0.00195	0.00304	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—TACR1—bipolar disorder	0.00195	0.00304	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—TRPC3—bipolar disorder	0.00191	0.00297	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—ADM—bipolar disorder	0.00182	0.00284	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00178	0.00277	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—PDE4B—bipolar disorder	0.00177	0.00276	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—TSHB—bipolar disorder	0.00177	0.00276	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—TACR1—bipolar disorder	0.00177	0.00276	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—AKR1C4—bipolar disorder	0.00177	0.00275	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—HTR2A—bipolar disorder	0.00169	0.00264	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DGKH—bipolar disorder	0.00163	0.00253	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00162	0.00252	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—TAC1—bipolar disorder	0.00159	0.00248	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—HTR2C—bipolar disorder	0.00156	0.00243	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD1—bipolar disorder	0.00156	0.00243	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD3—bipolar disorder	0.00151	0.00236	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD5—bipolar disorder	0.00149	0.00232	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—HTR1A—bipolar disorder	0.00147	0.00229	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD4—bipolar disorder	0.00147	0.00229	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—RGS4—bipolar disorder	0.00146	0.00227	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—TAC1—bipolar disorder	0.00145	0.00225	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—HTR2C—bipolar disorder	0.00142	0.00221	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD1—bipolar disorder	0.00142	0.00221	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—ADCY2—bipolar disorder	0.00138	0.00215	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD3—bipolar disorder	0.00137	0.00214	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	0.00137	0.00213	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—POMC—bipolar disorder	0.00135	0.00211	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD4—bipolar disorder	0.00133	0.00208	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	0.00125	0.00196	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD2—bipolar disorder	0.00124	0.00194	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—TRPC3—bipolar disorder	0.00113	0.00176	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—ADM—bipolar disorder	0.00107	0.00168	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—TSHB—bipolar disorder	0.00105	0.00163	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—TACR1—bipolar disorder	0.00105	0.00163	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—PDE4B—bipolar disorder	0.00105	0.00163	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000957	0.00149	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	0.000869	0.00136	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	0.000867	0.00135	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—TAC1—bipolar disorder	0.000854	0.00133	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD1—bipolar disorder	0.000837	0.00131	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	0.000837	0.00131	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	0.000814	0.00127	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD3—bipolar disorder	0.000811	0.00126	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	0.000807	0.00126	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD4—bipolar disorder	0.000787	0.00123	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	0.000765	0.00119	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	0.000741	0.00116	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	0.000738	0.00115	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD2—bipolar disorder	0.000733	0.00114	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—POMC—bipolar disorder	0.000694	0.00108	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	0.000664	0.00103	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—S100B—bipolar disorder	0.000645	0.00101	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—NRG1—bipolar disorder	0.00057	0.000888	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	0.000514	0.000801	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	0.000414	0.000645	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—POMC—bipolar disorder	0.00041	0.000639	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—INS—bipolar disorder	0.000408	0.000636	CbGpPWpGaD
